Precigen, Inc. (NASDAQ:PGEN) Q4 2024 Earnings Call Transcript
Operator: Good evening, and welcome to the Precigen's Full Year 2024 Financial Results and Business Update Call. At this time, all lines are in listen-only mode.
Posts Tagged ‘NASDAQ:PGEN’
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
Should You Invest in Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2024 investor letter.
Should you Hold Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can...
Precigen, Inc. (NASDAQ:PGEN) Q2 2024 Earnings Call Transcript
Precigen, Inc. (NASDAQ:PGEN) Q2 2024 Earnings Call Transcript August 14, 2024Precigen, Inc. misses on earnings expectations.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript
Precigen, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.08.
Precigen, Inc. (NASDAQ:PGEN) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Precigen Second Quarter and First Half 2023 Financial Results and Business Update Call. Please note this event is being recorded.
Precigen, Inc. (NASDAQ:PGEN) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Precigen First Quarter 2023 Financial Results and Business Update Call. All participants will be in the listen-only mode.
5 High Growth Penny Stocks that are Profitable
In this piece, we will take a look at the five high growth penny stocks that are profitable.
5 High Growth Pharma Stocks that are Profitable
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company that develops treatments for lymphoma, immune disorders, cancer, and leukemia.
Hedge Fund and Insider Trading News: Julian Robertson, Ray Dalio, Paul Tudor Jones, Steve Cohen, Third Point LLC, Archegos Capital Management, Tesla Inc (TSLA), Precigen Inc (PGEN), and More
Julian Robertson is an investor and former hedge fund manager.
Were Hedge Funds Right About Precigen, Inc. (PGEN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is It Too Late to Buy Precigen (PGEN) Stock?
Miller Value Partners recently released its Q1 2021 Investor Letter, a copy of which you can download here.
Is PGEN A Good Stock To Buy Now?
In this article we will check out the progression of hedge fund sentiment towards Precigen, Inc. (NASDAQ:PGEN) and determine whether it is a good investment right now.
Miller Value Partners is Betting on Precigen (PGEN) Stock
Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here.
